MarketPulse
H

$HTGC

32 articles found
1 positive
31 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Hercules Capital Plummets on Short Seller Allegations of Deal Sourcing Fraud

Hercules Capital ($HTGC) faces securities class action after short seller claims Google Ventures copying, valuation overstatement, and PIK loan misuse.
HCXYHTGCsecurities class actionbusiness development company
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Hercules Capital Faces Securities Fraud Suit Over Valuation Procedures

Hercules Capital ($HTGC) sued for securities fraud over alleged misleading valuation statements. Stock dropped 7.9% in February; investors can seek lead plaintiff status.
HCXYHTGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Hercules Capital Faces Class Action Over Alleged Due Diligence Lapses, Stock Tumbles 7.9%

Robbins LLP sued Hercules Capital for allegedly overstating due diligence and misclassifying portfolio investments, triggering a 7.9% stock decline following damaging media report.
HCXYHTGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Hercules Capital Faces Class Action Over Valuation Disclosure; Investor Deadline Looms

Rosen Law Firm files securities class action against $HTGC alleging false statements on valuations and due diligence. Lead plaintiff deadline: May 19, 2026.
MNDYHCXYHTGCALDXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm filed a securities class action against Aldeyra Therapeutics for alleged false statements. Affected investors must act by May 29, 2026 to become lead plaintiffs.
MNDYHCXYHTGCALDXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Corcept Investors Face April Deadline in Securities Fraud Class Action Over Drug Trial Data

Rosen Law Firm files securities fraud class action against Corcept Therapeutics, alleging misrepresentation of relacorilant drug trial data. Lead plaintiff deadline: April 21, 2026.
CORTMNDYHCXYHTGCsecurities class actionrelacorilant
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Hercules Capital Hit with Class Action Over False Statements on Deal Due Diligence

Class action lawsuit filed against $HCA alleging materially false statements regarding due diligence, loan origination, and portfolio valuation between May 2025 and February 2026.
HCXYHTGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Gainey Mckenna & Egleston

Hercules Capital Faces Securities Lawsuit Over Portfolio Valuation Claims

Class action lawsuit filed against $HTGC alleging overstated due diligence and misrepresented portfolio valuations in loan origination and deal sourcing processes.
PSIXHCXYHTGCCIGLsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Hercules Capital Under Fire: Law Firm Launches Fraud Investigation Over Valuation Claims

Pomerantz Law Firm investigates $HTGC for potential securities fraud following short-seller allegations of inflated software debt valuations and rising payment-in-kind loans.
HCXYHTGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

Alight Faces Securities Lawsuit Over Dividend Claims as Legal Scrutiny Intensifies

Law firm Holzer & Holzer filed class action lawsuit against $ALIT for allegedly making false dividend statements. Multiple companies now under investigation.
ALITHCXYHTGCGOsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Adam Spatacco

Hercules Capital Shows Conviction With $1.9M Insider Buying Amid Dividend Strength

Hercules Capital insiders bought $1.9M in stock in February amid record $3.9B investment commitments and a fortress 120% dividend coverage ratio, signaling management confidence despite 52-week lows.
HCXYHTGCdividend stockbusiness development company
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Hercules Capital Under Legal Scrutiny After 10% Plunge on Valuation Concerns

Johnson Fistel investigates Hercules Capital after 10% stock drop following research reports questioning valuation practices and PIK income reporting.
HCXYHTGCinvestor protectionfederal securities laws